Abstract: Internal Medicine JournalVolume 45, Issue 5 p. 591-591 Letter to the Editor Author reply R. J. Commons, R. J. Commons Departments of, Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, AustraliaSearch for more papers by this authorR. Hannah, R. Hannah Departments of, Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia Immunology, Royal Darwin Hospital, Darwin, Northern Territory, AustraliaSearch for more papers by this authorB. J. Currie, B. J. Currie Departments of, Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, AustraliaSearch for more papers by this author R. J. Commons, R. J. Commons Departments of, Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, AustraliaSearch for more papers by this authorR. Hannah, R. Hannah Departments of, Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia Immunology, Royal Darwin Hospital, Darwin, Northern Territory, AustraliaSearch for more papers by this authorB. J. Currie, B. J. Currie Departments of, Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, AustraliaSearch for more papers by this author First published: 08 May 2015 https://doi.org/10.1111/imj.12744Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Nossent JC. Not only monoclonal antibodies … Intern Med J 2015; 45: 590. 2Commons RJ, Grivas R, Currie BJ. Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis. Intern Med J 2014; 44: 1245–1246. 3Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010; 4: e900. 4Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis and treatment. Semin Respir Crit Care Med 2015; 36: 111–125. 5Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 1999; 67: 3593–3600. 6Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375–381. 7Bodro M, Paterson DL. Listeriosis in patients receiving biologic therapies. Eur J Clin Microbiol Infect Dis 2013; 32: 1225–1230. Volume45, Issue5May 2015Pages 591-591 ReferencesRelatedInformation
Publication Year: 2015
Publication Date: 2015-05-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot